Gastroesophageal reflux disease in neonates and infants: When and how to treat

Pediatric Drugs

Volumn 15, Issue 1, 2013, Pages 19-27

  Czinn, Steven J ^a   Blanchard, Samra ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE;

ARTICLE; CERVICAL DYSTONIA; CHILDHOOD DISEASE; DISTRESS SYNDROME; ESOPHAGITIS; FAILURE TO THRIVE; FEEDING DISORDER; GASTROESOPHAGEAL REFLUX; HEMATEMESIS; IRRITABILITY; LOWER ESOPHAGUS SPHINCTER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; SANDIFER SYNDROME; SLEEP DISORDER; STOMACH CONTENT; STOMACH PRESSURE; SWALLOWING; VOMITING;

AGE FACTORS; DIET; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; INFANT; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN;

EID: 84873377134     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.1007/s40272-012-0004-2     Document Type: Article

References (73)

1. Sherman PM, Hassall E, Fagundes-Neto U, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol. 2009;104:1278-95.
2. Hegar B, Dewanti NR, Kadim M, et al. Natural evolution of regurgitation in healthy infants. Acta Paediatr. 2009;98:1189-93.
3. Osatakul S, Sriplung H, Puetpaiboon A, et al. Prevalence and natural course of gastroesophageal reflux symptoms: a 1-year cohort study in Thai infants. J Pediatr Gastroenterol Nutr. 2002;34(1):63-7.
4. Martin AJ, Pratt N, Kennedy JD, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics. 2002;109:1061-7.
5. Vandeplas Y, Goyvaerts H, Helven R, et al. Gastroesophageal reflux, as measured by 24-hour pH monitoring, in 509 healthy infants screened for risk of sudden infant death syndrome. Pediatrics. 1991;88:834-40.
6. Coletti RB, DiLorenzo C. Overview of pediatric gastroesophageal reflux disease and proton pump inhibitor therapy. J Pediatr Gastroenterol Nutr. 2003;37:S7-11.
7. Omari TI, Barnett CP, Benninga MA, et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut. 2002;51(4):475-9.
8. Davidson G. The role of lower esophageal sphincter function and dysmotility in gastroesophageal reflux in premature infants and in the first year of life. J Pediatr Gastroenterol Nutr. 2003;37:S17-22.
9. Omari TI, Miki K, Fraser R, et al. Esophageal body and lower esophageal sphincter function in healthy premature infants. Gastroenterology. 1995;109:1757-64.
10. Di Lorenzo C, Mertz H, Alvarez S, et al. Gastric receptive relaxation is absent in newborn infants [abstract]. Gastroenterology. 1993;104:A498.
11. Ravelli AM, Tobanelli P, Volpi S, et al. Vomiting and gastric motility in infants with cow's milk allergy. J Pediatr Gastroenterol Nutr. 2001;32:59-64.
12. Jadcherla SR, Duong HQ, Hoffmann RG, et al. Esophageal body and upper esophageal sphincter motor responses to esophageal provocation during maturation in preterm newborns. J Pediatr. 2003;143:31-8.
13. Kelly EJ, Newell SJ, Brownlee KG, et al. Gastric acid secretion in preterm infants. Early Hum Dev. 1993;35:215-20.
14. Weisselberg B, Yahav J, Reichman B, et al. Basal and meal-stimulated pepsinogen secretion in preterm infants: a longitudinal study. J Pediatr Gastroenterol Nutr. 1992;15:58-62.
15. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2009;49(4):498-547.
16. Khan S, Orenstein SR. Gastroesophageal reflux disease in infants and children. In: Granderath FA, Kamolz T, Pointner R, editors. Gastroesophageal reflux disease. New York: Springer; 2006. p. 45-64.
17. Feranchak AP, Orenstein SR, Cohn JF. Behaviors associated with onset of gastroesophageal reflux episodes in infants: prospective study using split-screen video and pH probe. Clin Pediatr. 1994;33:654-62.
18. Vandenplas Y, Badriul H, Verghote M, et al. Oesophageal pH monitoring and reflux oesophagitis in irritable infants. Eur J Pediatr. 2004;163:300-4.
19. Salvatore S, Vandenplas Y. Gastroesophageal reflux and cow milk allergy: is there a link? Pediatrics. 2002;110:972-84.
20. Nielsen RG, Bindslev-Jensen C, Kruse-Andersen S, et al. Severe gastroesophageal reflux disease and cow milk hypersensitivity in infants and children: disease association and evaluation of a new challenge procedure. J Pediatr Gastroenterol Nutr. 2004;39:383-91.
21. Poets CF. Apnea of prematurity: what can observational studies tell us about pathophysiology. Sleep Med. 2010;11:701-7.
22. Kimball AL, Carlton DP. Gastroesophageal reflux medications in the treatment of apnea in premature infants. J Pediatr. 2001;138:355-60.
23. Orenstein SR, Shalaby TM, Cohn JF. Reflux symptoms in 100 normal infants: diagnostic validity of the infant gastroesophageal reflux questionnaire. Clin Pediatr. 1996;35:607-14.
24. Kleinman L, Rothman M, Strauss R, et al. The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument. Clin Gastroenterol Hepatol. 2006;4:588-96.
25. Aggarwal S, Mittal SK, Kalra KK, et al. Infant gastroesophageal reflux disease score: reproducibility and validity in a developing country. Trop Gastroenterol. 2004;25:96-8.
26. Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008;103(3):753-63.
27. Mousa HM, Rosen R, Woodley WW, et al. Esophageal impedance monitoring for gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 2011;52:129-39.
28. Vandenplas Y. Oesophageal pH monitoring for gastroesophageal reflux in infants and children. New York: Wiley; 1992. p. 235-44.
29. Dahms BB. Reflux esophagitis: sequelae and differential diagnosis in infants and children including eosinophilic esophagitis. Pediatr Dev Pathol. 2004;7:5-16.
30. Heine RG, Cameron DJ, Chow CW, et al. Esophagitis in distressed infants: poor diagnostic agreement between esophageal pH monitoring and histopathologic findings. J Pediatr. 2002;140(1):14-9.
31. Wenzl TG. Role of diagnostic tests in GERD. J Pediatr Gastroenterol Nutr. 2011;53:S4-6.
32. Lopez-Alonso M, Moya MJ, Cabo JA, et al. Twenty-four hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acid, and weakly alkaline gastroesophageal reflux. Pediatrics. 2006;118:299-308.
33. Shalaby TM, Orenstein SR. Efficacy of telephone teaching of conservative therapy for infants with symptomatic gastroesophageal reflux referred by pediatricians to pediatric gastroenterologist. J Pediatr. 2003;142:57-61.
34. Horvath A, Dziechciarz P, Szajewska H. The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized, controlled trials. Pediatrics. 2008;122:e1268-77.
35. Iacono G, Carroccio A, Cavataio F, et al. Gastroesophageal reflux and cow's milk allergy in infants: a prospective study. J Allergy Clin Immunol. 1996;97(3):822-7.
36. Meyers WF, Herbst JJ. Effectiveness of positioning therapy for gastroesophageal reflux. Pediatrics. 1982;62:768-72.
37. American Academy of Pediatrics Task Force on Infant Sleep Position and Sudden Infant Death Syndrome. Changing concepts of sudden infant death syndrome: Implications for Infant sleep environment and sleep position. Pediatrics. 2000;105:650-6.
38. American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome. The changing concept of sudden death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk. Pediatrics. 2005;116:1245-55.
39. Omari TI, Rommel N, Staunton E, et al. Paradoxical impact of body position on gastroesophageal reflux and gastric emptying in the premature neonate. J Pediatr. 2004;145:194-200.
40. Van Wijk MP, Benniga MA, et al. Effect of body position changes on post prandial gastroesophageal reflux and gastric emptying in the healthy premature neonate. J Pediatr. 2007;151:591-6.
41. Del Buono R, Wenzl TG, Ball G, et al. Effect of Gaviscon Infant on gastroesophageal reflux in infants assessed by combined intraluminal impedance /pH. Arch Dis Child. 2005;90:460-3.
42. Levi P, Marmo F, Saluzzo C, et al. Bethanechol versus antiacids in treatment of gastroesophageal reflux. Helv Paediatr Acta. 1985;40(5):349-59.
43. Tighe MP, Afazal NA, Bevan A, et al. Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review. Pediatr Drugs. 2009;11(3):185-202.
44. Carroccio A, Iacono G, Montalto F, et al. Domperidone plus magnesium hydroide and aluminium hydroxide: a valid therapy in children with gastroesophageal reflux. Scand J Gastroenterol. 1994;29:300-4.
45. Grill BB, Hillemeier C, Semeraro LA, et al. Effects of domperidone therapy on symptoms and upper gastrointestinal motility in infants with gastro-oesophageal reflux. J Pediatr. 1985;106:311-6.
46. Pritchard DS, Baber N, Stephenson T. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old. Br J Clin Pharmacol. 2005;59:725-9.
47. Vandenplas Y, ESPGHAN Cisapride Panel, European Society for Pediatric Gastroenterology, Hepatology and Nutrition. Current pediatric indications for cisapride. J Pediatr Gastroenterol Nutr. 2000;31(5):480-9.
48. Maclennan S, Augood C, Cash-Gibson L, et al. Cisapride treatment for gastro-oesophageal reflux in children. Cochrane Database Syst Rev. 2010;(4):CD002300.
49. Khoshoo V, Edell D, Clarke R. Effect of cisapride on the QT interval in infants with gastroesophageal reflux. Pediatrics. 2000;105:e24.
50. Tolia V, Calhoun J, Kuhns L, et al. Randomized, prospective double blind trial of metoclopramide and placebo for gastroesophageal reflux in infants. J Pediatr. 1989;115:141-5.
51. De Loore I, Van Ravensteyn H, Ameryckx L. Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation: a comparison with metoclopramide. Postgrad Med J. 1979;55(Suppl. 1):40-2.
52. Jadcherla SR, Berseth CL. Effect of erythromycin on gastroduodenal contractile activity in developing neonates. J Pediatr Gastroenterol Nutr. 2002;34:16-22.
53. Cooper WO, Griffin MR, Arbogast P, et al. Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med. 2002;156:647-50.
54. Ng E, Shah VS. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants. Cochrane Database Syst Rev. 2008;(3):CD001815.
55. Omari T, Benninga M, Sansom L, et al. Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial. J Pediatr. 2006;149(4):468-74.
56. Moran LR, Cincotta T, Krishnamoorthy K, et al. The use of baclofen in full-term neonates with hypertonia. J Perinatol. 2005;25:66-8.
57. Cucchiara S, Gobio-Casali L, Balli F, et al. Cimetidine treatment of reflux esophagitis in children: an Italian multicentric study. J Pediatr Gastroenterol Nutr. 1989;8:150-6.
58. Oderda G, Dell'olio D, Forni M, et al. Treatment of childhood peptic oesophagitis with famotidine and alginate-antacid. Ital J Gastroenterol. 1990;22:346-9.
59. Simeone D, Caria MC, Miele E, et al. Treatment of childhood esophagitis: a double-blind placebo-controlled trial of nizatidine. J Pediatr Gastroenterol Nutr. 1997;25:51-5.
60. Mallet E, Mouterde O, Dubois F, et al. Use of ranitidine in young infants with gastro-oesophageal reflux. Eur J Clin Pharmacol. 1989;36:641-2.
61. Kuusela A. Long-term gastric pH monitoring for determining optimal dose of ranitidine for critically ill preterm and term neonates. Arch Dis Child Fetal Neonatal Ed. 1998;78:F151-3.
62. Ribeiro JM, Lucas M, Baptista A, et al. Fatal hepatitis associated with ranitidine. Am J Gastroenterol. 2000;95:559-60.
63. Garcia Rodriguez LA, Wallander MA, Stricker BH. The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs. Br J Clin Pharmacol. 1997;43:183-8.
64. Garcia Rodriguez LA, Jick H. Risk of gynecomastia associated with cimetidine, omeprazole and other antiulcer drugs. BMJ. 1994;308:503-6.
65. Stedman CAM, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther. 2000;14:963-78.
66. Barron JJ, Tan H, Spalding J, et al. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45:421-7.
67. Moore DJ, Tao BS, Lines DR, et al. Double-blind placebo controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr. 2003;143:219-23.
68. Orenstein SR, Hassall E, Furmaga-Jablonska W, et al. Multicenter, double-blind, randomized, placebo controlled trial assessing efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154:514-20.
69. Tsou VM, Young RM, Hart MH, et al. Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum. Pediatrics. 1991;87(2):148-51.
70. Omari TI, Haslam RR, Lundborg P, et al. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological reflux. J Pediatr Gastroenterol Nutr. 2007;44:41-4.
71. Sorbie AL, Symon DN, Stockdale EJ. Gaviscon bezoars. Arch Dis Child. 1984;59(9):905-6.
72. Portuguez-Malavasi A, Aranda JV. Antacid bezoar in a newborn. Pediatrics. 1979;63:679-80.
73. Hassall E. Talk is cheap, often effective: symptoms in infants often respond to non-pharmacologic measures. J Pediatr. 2008;152:301-3.